Literature DB >> 11227889

Leishmanicidal activity of stearylamine-bearing liposomes in vitro.

F Afrin1, T Dey, K Anam, N Ali.   

Abstract

Liposomes consisting of stearylamine (SA) and egg yolk phosphatidylcholine (PC) were studied for their cytotoxic activity against freshly transformed promastigotes and intracellular amastigotes of Leishmania donovani, the causative agent of visceral leishmaniasis. More than 99% of the parasites of strain AG83 were killed within 60 min by treatment with 22 mol% SA-PC liposomes (132 microg/ml total lipids). This was further confirmed by incubating the liposome-treated promastigotes at 22 C for 96 hr. The killing activity of the liposomes progressively decreased with lowering lipid concentration. However, weak cytotoxic activity was still detected at 6.6 microg/ml lipids. Leishmanicidal activity of the liposomes became stronger with increasing SA content but was reduced with the incorporation of cholesterol in the liposomes. A similar cytotoxic effect was observed on other Indian strains of L. donovani, for example PKDL and DD8, as well as on species such as Leishmania donovani S1, Leishmania donovani infantum, Leishmania tropica, Leishmania amazonensis, and Leishmania mexicana. However, freshly transformed promastigotes appeared to be more susceptible than the ones subcultured. The strong leishmanicidal activity of SA-PC liposomes was also demonstrated toward intracellular L. donovani amastigotes. The SA-bearing vesicles could effectively inhibit the growth and multiplication of the parasites within the macrophages. The cytolytic activity of these liposomes on leishmanial parasites and low toxicity on host macrophages may, thus, find application in the therapy of leishmaniasis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11227889     DOI: 10.1645/0022-3395(2001)087[0188:LAOSBL]2.0.CO;2

Source DB:  PubMed          Journal:  J Parasitol        ISSN: 0022-3395            Impact factor:   1.276


  12 in total

1.  Cationic liposomal sodium stibogluconate (SSG), a potent therapeutic tool for treatment of infection by SSG-sensitive and -resistant Leishmania donovani.

Authors:  Roma Sinha; Jayeeta Roychoudhury; Partha Palit; Nahid Ali
Journal:  Antimicrob Agents Chemother       Date:  2014-11-03       Impact factor: 5.191

2.  Zinc(II)-Dipicolylamine Coordination Complexes as Targeting and Chemotherapeutic Agents for Leishmania major.

Authors:  Douglas R Rice; Paola Vacchina; Brianna Norris-Mullins; Miguel A Morales; Bradley D Smith
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

3.  Combination therapy with paromomycin-associated stearylamine-bearing liposomes cures experimental visceral leishmaniasis through Th1-biased immunomodulation.

Authors:  Antara Banerjee; Manjarika De; Nahid Ali
Journal:  Antimicrob Agents Chemother       Date:  2011-01-10       Impact factor: 5.191

4.  Vaccination route that induces transforming growth factor beta production fails to elicit protective immunity against Leishmania donovani infection.

Authors:  Sudipta Bhowmick; Tuhina Mazumdar; Nahid Ali
Journal:  Infect Immun       Date:  2009-01-21       Impact factor: 3.441

5.  Therapy with sodium stibogluconate in stearylamine-bearing liposomes confers cure against SSG-resistant Leishmania donovani in BALB/c mice.

Authors:  Jayeeta Roychoudhury; Roma Sinha; Nahid Ali
Journal:  PLoS One       Date:  2011-03-10       Impact factor: 3.240

6.  Inhibition of the Growth of Plasmodium falciparum in Culture by Stearylamine-Phosphatidylcholine Liposomes.

Authors:  Gulam Mustafa Hasan; Neha Garg; Enna Dogra; Ranu Surolia; Prahlad Chandra Ghosh
Journal:  J Parasitol Res       Date:  2011-06-14

7.  Leishmanicidal activities of Artemisia annua leaf essential oil against Visceral Leishmaniasis.

Authors:  Mohammad Islamuddin; Garima Chouhan; Maujiram Tyagi; Malik Z Abdin; Dinkar Sahal; Farhat Afrin
Journal:  Front Microbiol       Date:  2014-11-25       Impact factor: 5.640

8.  β-Nitrostyrenes as Potential Anti-leishmanial Agents.

Authors:  Syed Shafi; Farhat Afrin; Mohammad Islamuddin; Garima Chouhan; Intzar Ali; Faatima Naaz; Kalicharan Sharma; Mohammad S Zaman
Journal:  Front Microbiol       Date:  2016-09-01       Impact factor: 5.640

9.  Elucidating the possible mechanism of action of some pathogen box compounds against Leishmania donovani.

Authors:  Wandayi Emmanuel Amlabu; Christine Achiaa Antwi; Gordon Awandare; Theresa Manful Gwira
Journal:  PLoS Negl Trop Dis       Date:  2020-04-10

10.  Isolation, characterization and antimicrobial evaluation of a novel compound N-octacosan 7β ol, from Fumaria parviflora Lam.

Authors:  Mohammad Jameel; Mohammad Islamuddin; Abuzer Ali; Farhat Afrin; Mohammed Ali
Journal:  BMC Complement Altern Med       Date:  2014-03-12       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.